332 related articles for article (PubMed ID: 23642698)
1. Understanding the Tobacco Control Act: efforts by the US Food and Drug Administration to make tobacco-related morbidity and mortality part of the USA's past, not its future.
Husten CG; Deyton LR
Lancet; 2013 May; 381(9877):1570-80. PubMed ID: 23642698
[TBL] [Abstract][Full Text] [Related]
2. No sisyphean task: how the FDA can regulate electronic cigarettes.
Paradise J
Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
[TBL] [Abstract][Full Text] [Related]
3. Research gaps related to tobacco product marketing and sales in the Family Smoking Prevention and Tobacco Control Act.
Ribisl KM
Nicotine Tob Res; 2012 Jan; 14(1):43-53. PubMed ID: 21690316
[TBL] [Abstract][Full Text] [Related]
4. Permissive nicotine regulation as a complement to traditional tobacco control.
Sumner W
BMC Public Health; 2005 Feb; 5():18. PubMed ID: 15730554
[TBL] [Abstract][Full Text] [Related]
5. The need for FDA regulation of tobacco products.
Kennedy EM
Yale J Health Policy Law Ethics; 2002; 3(1):101-8. PubMed ID: 12825428
[No Abstract] [Full Text] [Related]
6. FDA's misplaced priorities: premarket review under the Family Smoking Prevention and Tobacco Control Act.
Jenson D; Lester J; Berman ML
Tob Control; 2016 May; 25(3):246-53. PubMed ID: 27068243
[TBL] [Abstract][Full Text] [Related]
7. Federal approaches to the regulation of noncigarette tobacco products.
Freiberg MJ
Am J Prev Med; 2012 Nov; 43(5 Suppl 3):S249-54. PubMed ID: 23079224
[TBL] [Abstract][Full Text] [Related]
8. Using findings from a public opinion poll to build political support for tobacco control policy in Kenya.
Maina WK; Kitonyo R; Ogwell AE
Tob Control; 2013 Nov; 22(6):423-6. PubMed ID: 22628169
[TBL] [Abstract][Full Text] [Related]
9. Tobacco regulatory science: research to inform regulatory action at the Food and Drug Administration's Center for Tobacco Products.
Ashley DL; Backinger CL; van Bemmel DM; Neveleff DJ
Nicotine Tob Res; 2014 Aug; 16(8):1045-9. PubMed ID: 24638850
[TBL] [Abstract][Full Text] [Related]
10. Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.
Tan CE; Kyriss T; Glantz SA
PLoS Med; 2013; 10(5):e1001450. PubMed ID: 23723740
[TBL] [Abstract][Full Text] [Related]
11. Research on Youth and Young Adult Tobacco Use, 2013-2018, From the Food and Drug Administration-National Institutes of Health Tobacco Centers of Regulatory Science.
Perry CL; Creamer MR; Chaffee BW; Unger JB; Sutfin EL; Kong G; Shang C; Clendennen SL; Krishnan-Sarin S; Pentz MA
Nicotine Tob Res; 2020 Jun; 22(7):1063-1076. PubMed ID: 31127298
[TBL] [Abstract][Full Text] [Related]
12. Support for a tobacco endgame and increased regulation of the tobacco industry among New Zealand smokers: results from a National Survey.
Edwards R; Wilson N; Peace J; Weerasekera D; Thomson GW; Gifford H
Tob Control; 2013 May; 22(e1):e86-93. PubMed ID: 22535362
[TBL] [Abstract][Full Text] [Related]
13. Single Cigarette Sales: State Differences in FDA Advertising and Labeling Violations, 2014, United States.
Baker HM; Lee JG; Ranney LM; Goldstein AO
Nicotine Tob Res; 2016 Feb; 18(2):221-6. PubMed ID: 25744967
[TBL] [Abstract][Full Text] [Related]
14. The FDA and graphic cigarette-pack warnings--thwarted by the courts.
Bayer R; Johns D; Colgrove J
N Engl J Med; 2013 Jul; 369(3):206-8. PubMed ID: 23803139
[No Abstract] [Full Text] [Related]
15. Oklahoma tobacco policy-making.
Givel M
J Okla State Med Assoc; 2005 Mar; 98(3):89-94. PubMed ID: 15822722
[TBL] [Abstract][Full Text] [Related]
16. Philip Morris' FDA gambit: good for public health?
Givel M
J Public Health Policy; 2005 Dec; 26(4):450-68. PubMed ID: 16392744
[TBL] [Abstract][Full Text] [Related]
17. Tobacco control: National Action Plan for NCD Prevention, Control and Health Promotion in Pakistan.
Nishtar S; Mirza Z; Mohamud KB; Latif E; Ahmed A; Jafarey NA
J Pak Med Assoc; 2004 Dec; 54(12 Suppl 3):S31-41. PubMed ID: 15745325
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation.
Chaloupka FJ; Warner KE; Acemoğlu D; Gruber J; Laux F; Max W; Newhouse J; Schelling T; Sindelar J
Tob Control; 2015 Mar; 24(2):112-9. PubMed ID: 25550419
[TBL] [Abstract][Full Text] [Related]
19. Q&A: Mitchell Zeller on the FDA and tobacco.
Zeller M; Rose S
Cancer Discov; 2014 Jan; 4(1):10-1. PubMed ID: 24402930
[TBL] [Abstract][Full Text] [Related]
20. Flavoured tobacco products in the USA: synthesis of recent multidiscipline studies with implications for advancing tobacco regulatory science.
Stanton CA; Villanti AC; Watson C; Delnevo CD
Tob Control; 2016 Nov; 25(Suppl 2):ii1-ii3. PubMed ID: 27856996
[No Abstract] [Full Text] [Related]
[Next] [New Search]
